ERCC1 and cervical cancer: High ERCC1 expression was a poor prognostic factor and was correlated with poor disease-free survival (DFS) (p = 0.021) and OS (p = 0.005) in 88 locally advanced cervical cancer (LACC) patients who received cisplatin monotherapy as reported by Zwenger et al. [32].